Glutamine parenteral supplementation in stem cell transplant (multiple letters) [1]

Bone Marrow Transplantation

Volumn 33, Issue 4, 2004, Pages 455-457

  Piccirillo, N ^a   De Matteis, S ^a   Sora F ^a   Laurenti, L ^a   Chiusolo, P ^a   Leone, G ^a   Sica, S ^a   Pytlik, R ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLGLUTAMINE; CD16 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GLUTAMINE; OPIATE; PLACEBO;

CLINICAL PRACTICE; DIET SUPPLEMENTATION; DISEASE DURATION; DISEASE SEVERITY; ECONOMIC ASPECT; FEVER; HEALTH STATUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LENGTH OF STAY; LETTER; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RECURRENCE RISK; SAFETY; STEM CELL TRANSPLANTATION; SURVIVAL; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME;

DIPEPTIDES; GLUTAMINE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PARENTERAL NUTRITION; TREATMENT OUTCOME;

EID: 1542329680     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704363     Document Type: Letter

References (0)